The United Kingdom Coordinating Committee on Cancer Research represents the major organisations funding cancer research in the United Kingdom.
The deliberations of a working party convened by the committee to evaluate recently expressed concerns that the changes in the NHS threatenresearch, especially clinical trials to evaluate new treatments, are reported.
A survey of contributors to vials coordinated by the committee showed that half are now experiencing difficulties in continuing to participate in clinical trials.
The two major problems identified were lack of time and of staff, especially for NHS staff in non-teaching hospitals.
Recent changes in junior doctors hours and proposed reductions in the length of time for training will exacerbate this.
Mots-clés Pascal : Tumeur, Recherche scientifique, Royaume Uni, Essai clinique, Homme, Europe, Organisation santé
Mots-clés Pascal anglais : Tumor, Scientific research, United Kingdom, Clinical trial, Human, Europe, Public health organization
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0028413
Code Inist : 002B30A01C. Création : 09/06/1995.